openPR Logo
Press release

Muscle Relaxant Drugs Market Growth Opportunities and Country Level Segments, Share Analysis of The Top Industry Players Like Roche, Johnson & Johnson, GlaxoSmithKline, Intas Pharmaceuticals, Pfizer, Merck & Co

11-20-2018 04:55 AM CET | Health & Medicine

Press release from: P&S Intelligence

Muscle Relaxant Drugs Market Growth Opportunities and Country

The global muscle relaxant drugs market is expected to grow with a CAGR of 5.5% during 2015 - 2020.The global muscle relaxant drugs market is growing, due to increasing aging population, increasing incidences of skin diseases and harmful effects of ultra violet radiation. In addition, the increasing usage of neuromuscular blocking agents in surgeries, and increase in disposable income are also driving the growth of the global muscle relaxant drugs market.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/muscle-relaxant-drugs-market

The information and data in the publication “Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by type and drugs. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/muscle-relaxant-drugs-market/report-sample

The increasing aging population is propelling the growth of the global muscle relaxant drugs market, since the elder population is more prone to illness due to low immunity levels, and high recovery time consumption. Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. The muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=muscle-relaxant-drugs-market

Geographically, North America dominated the global market of muscle relaxant drugs in 2014; whereas the Asian market is expected to witness the fastest growth during the forecast period.

The key companies operating in the global muscle relaxant drugs market include F. Hoffmann-La Roche Ltd., Johnson & Johnson, GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Pfizer Inc., Galderma S.A., and Merck & Co. Inc.

GLOBAL MUSCLE RELAXANT DRUGS MARKET SEGMENTATION
By Type
• Facial Aesthetic Relaxants
• Skeletal Muscle Relaxants
• Neuromuscular Blocking Agents

By Drug
• Facial Aesthetic Relaxant Drugs
o Botox
o Dysport
o Others

• Skeletal Muscle Relaxant Drugs
o Baclofen
o Methocarbamol
o Carisoprodol
o Metaxalone
o Tizanidine
o Others

• Neuromuscular Blocking Agents
o Non-Depolarizing Agents
o Polarizing Agents

Breakdown by Geography
• North America
o The U.S.
o Canada
o Rest of North America

• Europe
o Germany
o France
o The U.K.
o Rest of Europe

• Asia
o Japan
o China
o India
o Rest of Asia
• Rest of the World (RoW)

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Muscle Relaxant Drugs Market Growth Opportunities and Country Level Segments, Share Analysis of The Top Industry Players Like Roche, Johnson & Johnson, GlaxoSmithKline, Intas Pharmaceuticals, Pfizer, Merck & Co here

News-ID: 1383312 • Views:

More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period. According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sectors
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period. This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by Omnichannel Integration
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, and Growth Opportunities
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,

All 4 Releases


More Releases for Relaxant

Emerging Muscle Relaxant Drugs Market Trends: Innovative Muscle Relaxant With Fl …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Muscle Relaxant Drugs Market Size Growth Forecast: What to Expect by 2025? The market size for muscle relaxant drugs has seen substantial growth recently. It is projected to rise from $4.77 billion in 2024 to $5.16 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Reasons for this growth during the
Muscle Relaxant Drugs Market Global Competitive Analysis And Forecast 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company presents an extensive market research report on the Muscle Relaxant Drugs Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and
Muscle Relaxant Monitor Market to Witness Huge Growth 2023-2029
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Muscle Relaxant Monitor market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role in
Muscle Relaxant Monitor Market | Blink Device, GE, IDMED, Organon Laboratories
The global muscle relaxant monitor market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the muscle relaxant monitor market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Muscle Relaxant Drugs Market: Global Insights, Growth Opportunities, and Future …
The global muscle relaxant drugs market is expected to witness significant growth during the forecast period. Growing elderly populations globally who are more susceptible to musculoskeletal disorders is the primary factor driving the growth of the market. Muscle relaxants are powerful drugs; though, these can have serious side effects such as heart failure, sedation, and paralysis. In many patients, sedation is reported as the common adverse effect. Therefore, physicians generally
Surging Geriatric Population Fueling Muscle Relaxant Drugs Market Boom
A number of factors such as the rising incidence of skin diseases, growing awareness about the harmful effects of ultraviolet (UV) radiation, increasing use of neuromuscular blocking agents in surgical procedures, mushrooming population of geriatric people, and soaring disposable income of people are driving the expansion of the global muscle relaxant drugs market. According to the observations of the market research company, P&S Intelligence, the market grew at a CAGR